查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲肉毒桿菌毒素市场预测至2031 年- 区域分析- 按产品（肉毒桿菌毒素A 和肉毒桿菌毒素B）、应用（医疗和美容）和最终用户（专科和皮肤科诊所、医院和诊所等）
市场调查报告书
商品编码
1592660

欧洲肉毒桿菌毒素市场预测至2031 年- 区域分析- 按产品（肉毒桿菌毒素A 和肉毒桿菌毒素B）、应用（医疗和美容）和最终用户（专科和皮肤科诊所、医院和诊所等）

Europe Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product (Botulinum Toxin A and Botulinum Toxin B), Application (Medical and Aesthetic), and End User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others)
出版日期: | 出版商: The Insight Partners | 英文 75 Pages | 订单完成后即时交付

价格

2023年欧洲肉毒桿菌毒素市值为11.7494亿美元，预计到2031年将达到29.3174亿美元；预计2023年至2031年复合年增长率为12.1%。

欧洲人口老化推动欧洲肉毒桿菌毒素市场

欧洲人口老化为市场成长提供了重大机会。随着该地区的人口结构向老年人口倾斜，对肉毒桿菌等抗衰老治疗的需求也随之增加。随着老年人寻求非侵入性解决方案来保持年轻的外表，对真皮填充剂的需求不断增加。截至2023年1月1日，欧盟人口估计为4.488亿，其中近五分之一（21.3%）的人口年龄在65岁或以上。 2023 年 1 月 1 日，欧盟人口的中位数年龄达到 44.5 岁。

欧洲肉毒毒素市场概况

欧洲肉毒桿菌市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。欧洲在全球肉毒桿菌毒素市场中占据重要地位，预计在预测期内将录得强劲成长率。该地区的市场成长主要归因于肉毒毒素公司的产品开发以及德国、英国、法国和义大利等欧洲国家各个年龄层的人们对现代美容标准意识的高涨。此外，医疗保健系统的进步可能会在未来几年推动整个地区对肉毒桿菌毒素的需求。德国医疗保健产业在美容和医疗程序中采用先进技术。根据 ISAPS 的数据，2021 年全国共进行了 605,942 例非手术美容手术，其中包括 306,296 例肉毒桿菌治疗。因此，随着非手术整容手术数量的增加以及微创手术意识的增强，德国的肉毒桿菌市场预计将会成长。此外，该公司正在该国推出产品以供直接订单和客户交付。 2023 年 2 月，Evolus, Inc. 在德国商业推出 Nuceiva，用于直接订购和交付给客户。

欧洲肉毒桿菌毒素市场收入及 2031 年预测（百万美元）

欧洲肉毒桿菌毒素市场细分

欧洲肉毒桿菌毒素市场按产品、应用、最终用户和国家分类。

根据产品，欧洲肉毒桿菌毒素市场分为肉毒桿菌毒素A和肉毒桿菌毒素B。

从应用来看，欧洲肉毒桿菌市场分为医疗和美容。到2023年，医疗领域在欧洲肉毒桿菌毒素市场中占据较大份额。此外，美观部分也细分为皱眉纹/眉间纹、额头纹、鱼尾纹、方下巴/咬肌等。

依最终用户划分，欧洲肉毒桿菌市场分为专科和皮肤科诊所、医院和诊所等。 2023 年，专科诊所和皮肤科诊所占据欧洲肉毒桿菌市场的最大份额。

根据国家/地区，欧洲肉毒桿菌市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2023年，德国在欧洲肉毒桿菌毒素市场份额中占据主导地位。

Merz Pharma GmbH & Co KGaA、AbbVie Inc、Ipsen SA、Evolus Inc、Meditox Inc 和 Galderma SA 是欧洲肉毒桿菌毒素市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲肉毒桿菌毒素市场 - 主要市场动态

  • 市场驱动因素
    • 非侵入性美容手术日益普及
    • 增加肉毒桿菌毒素的使用以增强脸部美观
  • 市场限制
    • 肉毒桿菌毒素的副作用
  • 市场机会
    • 人口老化
  • 未来趋势
    • 扩大治疗应用
  • 驱动因素和限制的影响：

第 5 章：肉毒桿菌市场 - 欧洲分析

  • 概述
  • 肉毒桿菌市场收入，2021-2031

第 6 章：欧洲肉毒桿菌市场分析 - 按产品

  • 概述
  • A型肉毒桿菌毒素
  • 肉毒桿菌B

第 7 章：欧洲肉毒桿菌毒素市场分析 - 按应用

  • 概述
  • 医疗的
  • 美学的

第 8 章：欧洲肉毒桿菌毒素市场分析 - 按最终用户

  • 概述
  • 专科和皮肤科诊所
  • 医院和诊所
  • 其他的

第 9 章：欧洲肉毒桿菌毒素市场 - 国家分析

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 10 章：公司简介

  • Merz Pharma GmbH & Co KGaA
  • AbbVie Inc
  • Ipsen SA
  • Evolus Inc
  • Medytox Inc
  • Galderma SA

第 11 章：附录

Product Code: TIPRE00026638

The Europe botulinum toxin market was valued at US$ 1,174.94 million in 2023 and is expected to reach US$ 2,931.74 million by 2031; it is estimated to register a CAGR of 12.1% from 2023 to 2031 .

Aging Population in Europe Drives Europe Botulinum Toxin Market

The aging population in Europe presents a significant opportunity for market growth. As the region's demographic landscape shifts towards an older population, there is a parallel increase in demand for anti-aging treatments, such as botox. With older individuals seeking non-invasive solutions to maintain a youthful appearance, the demand for dermal fillers is increasing. As of January 1, 2023, the estimated population of the European Union was 448.8 million, with almost one-fifth (21.3%) of the population being 65 years of age or older. The EU's population reached a median age of 44.5 years on January 1, 2023. Advancements in filler technology that offer longer-lasting results and natural-looking outcomes cater to the preference of this demographic, further driving market expansion.

Europe Botulinum Toxin Market Overview

The Europe botulinum toxin market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global botulinum toxin market, and it is expected to record a strong growth rate during the forecast period. The market growth in the region is mainly attributed to product developments by botulinum toxin companies and an upsurge in the awareness of modern beauty standards among people from all age groups in European countries such as Germany, the UK, France, and Italy. In addition, advancements in healthcare systems are likely to propel the demand for botulinum toxin across the region in the coming years. The German healthcare sector utilizes advanced technologies in aesthetic and medical procedures. According to the ISAPS, a total of 605,942 nonsurgical aesthetic procedures were performed in the country in 2021, including 306,296 botulinum toxin treatments. Thus, the botulinum toxin market in Germany is expected to grow with the rising number of nonsurgical cosmetic procedures, and the growing awareness of minimally invasive procedures. Also, companies are launching products in the country for direct orders and customer delivery. In February 2023, Evolus, Inc. commercially launched Nuceiva in Germany for direct orders and delivery to customers.

Europe Botulinum Toxin Market Revenue and Forecast to 2031 (US$ Million)

Europe Botulinum Toxin Market Segmentation

The Europe botulinum toxin market is categorized into product, application, end user, and country.

Based on product, the Europe botulinum toxin market is bifurcated into botulinum toxin A and botulinum toxin B. The botulinum toxin A segment held a larger share of Europe botulinum toxin market share in 2023.

In terms of application, the Europe botulinum toxin market is bifurcated into medical and aesthetic. The medical segment held a larger share of Europe botulinum toxin market in 2023. Furthermore, the medical segment is subcategorized into chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis, and others. Additionally, the aesthetic segment is subcategorized into frown lines/ glabellar, forehead lines, crow's feet, square jaw/ masseter, and others.

By end user, the Europe botulinum toxin market is divided into specialty & dermatology clinics, hospitals & clinics, and others. The specialty and dermatology clinics segment held the largest share of Europe botulinum toxin market in 2023.

Based on country, the Europe botulinum toxin market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe botulinum toxin market share in 2023.

Merz Pharma GmbH & Co KGaA, AbbVie Inc, Ipsen SA, Evolus Inc, Medytox Inc, and Galderma SA are some of the leading companies operating in the Europe botulinum toxin market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Botulinum Toxin Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Popularity of Noninvasive Aesthetics Procedures
    • 4.1.2 Increasing Use of Botulinum Toxin for Enhancing Facial Aesthetics
  • 4.2 Market Restraints
    • 4.2.1 Side Effects of Botulinum Toxin
  • 4.3 Market Opportunities
    • 4.3.1 Aging Population
  • 4.4 Future Trends
    • 4.4.1 Expanding Therapeutic Applications
  • 4.5 Impact of Drivers and Restraints:

5. Botulinum Toxin Market - Europe Analysis

  • 5.1 Overview
  • 5.2 Botulinum Toxin Market Revenue (US$ Million), 2021-2031

6. Europe Botulinum Toxin Market Analysis - by Product

  • 6.1 Overview
  • 6.2 Botulinum Toxin A
    • 6.2.1 Overview
    • 6.2.2 Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Botulinum Toxin B
    • 6.3.1 Overview
    • 6.3.2 Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Botulinum Toxin Market Analysis - by Application

  • 7.1 Overview
  • 7.2 Medical
    • 7.2.1 Overview
    • 7.2.2 Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.2.2.1 Europe Botulinum Toxin Market Breakdown, by Medical
  • 7.3 Aesthetic
    • 7.3.1 Overview
    • 7.3.2 Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.3.2.1 Europe Botulinum Toxin Market Breakdown, by Aesthetic

8. Europe Botulinum Toxin Market Analysis - by End User

  • 8.1 Overview
  • 8.2 Specialty and Dermatology Clinics
    • 8.2.1 Overview
    • 8.2.2 Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Hospitals and Clinics
    • 8.3.1 Overview
    • 8.3.2 Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Botulinum Toxin Market - Country Analysis

  • 9.1 Europe: Botulinum Toxin Market
    • 9.1.1 Europe: Botulinum Toxin Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Germany
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.3 Germany: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.1.4 Germany: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.1.4.1 Germany: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.1.4.2 Germany: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.1.5 Germany: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.2 United Kingdom
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.3 United Kingdom: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.2.4 United Kingdom: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.2.4.1 United Kingdom: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.2.4.2 United Kingdom: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.2.5 United Kingdom: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.3 France
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.3 France: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.3.4 France: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.3.4.1 France: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.3.4.2 France: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.3.5 France: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.4 Italy
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.4.3 Italy: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.4.4 Italy: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.4.4.1 Italy: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.4.4.2 Italy: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.4.5 Italy: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.5 Spain
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.5.3 Spain: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.5.4 Spain: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.5.4.1 Spain: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.5.4.2 Spain: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.5.5 Spain: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.6 Rest of Europe
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.6.3 Rest of Europe: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.6.4 Rest of Europe: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.6.4.1 Rest of Europe: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.6.4.2 Rest of Europe: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.6.5 Rest of Europe: Botulinum Toxin Market Breakdown, by End User

10. Company Profiles

  • 10.1 Merz Pharma GmbH & Co KGaA
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 AbbVie Inc
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Ipsen SA
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Evolus Inc
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Medytox Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Galderma SA
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners

List Of Tables

  • Table 1. Botulinum Toxin Market Segmentation
  • Table 2. Europe Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 3. Europe Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 4. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 5. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 7. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 8. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 9. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 10. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 11. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 12. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 13. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 15. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 16. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 17. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 18. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 19. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 20. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 21. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 22. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 23. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 24. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 25. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 26. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 27. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 28. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 29. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 30. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 31. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 32. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 33. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Botulinum Toxin Market Segmentation, by Country
  • Figure 2. Botulinum Toxin Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Botulinum Toxin Market Revenue (US$ Million), 2021-2031
  • Figure 5. Botulinum Toxin Market Share (%) - by Product (2023 and 2031)
  • Figure 6. Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Botulinum Toxin Market Share (%) - by Application (2023 and 2031)
  • Figure 9. Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Botulinum Toxin Market Share (%) - by End User (2023 and 2031)
  • Figure 12. Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Europe: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 16. Europe: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 17. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)